Syndromic Sensorineural Deafness Due to Combined Oxidative Phosphorylation Defect

Syndromic sensorineural deafness due to combined oxidative phosphorylation defect is a very rare genetic disease. In this condition, a baby is born with permanent inner-ear hearing loss (sensorineural deafness), and at the same time has problems in many other organs such as the liver, kidneys, hormone glands, and blood-forming system. The word “combined oxidative phosphorylation defect” means that several parts (“complexes”) of the tiny power stations in our cells, called mitochondria, do not work properly, so the body cannot make energy efficiently.

Syndromic sensorineural deafness due to combined oxidative phosphorylation defect is a rare inherited disease of the tiny “power plants” inside cells, called mitochondria. In this condition, the machinery that makes energy (oxidative phosphorylation, or OXPHOS) does not work properly in many tissues, especially the inner ear, liver, and kidneys. Because of this, the hearing nerve and cochlea are damaged, causing permanent hearing loss from early life.

The problem is usually caused by harmful changes (mutations) in nuclear genes that build parts of the mitochondrial ribosome or respiratory chain. These genes help ribosomes in mitochondria make proteins that are needed for energy production. When these proteins are missing or faulty, the cell cannot make enough ATP, and toxic by-products like lactate build up. This energy failure hits organs that need a lot of energy first, such as the brain, hearing system, heart, liver, and kidneys.

“Combined oxidative phosphorylation defect” means that more than one complex (for example complex I, III, IV or V) in the respiratory chain is affected at the same time. The “syndromic” part means that hearing loss happens together with other features, such as high blood lactate, poor growth, low muscle tone, seizures, or liver and kidney problems. There is still no cure. Treatment focuses on reducing symptoms, protecting hearing and language development, and supporting overall health and quality of life.

This disease is part of a group called mitochondrial disorders. These disorders happen when the oxidative phosphorylation (OXPHOS) system, which normally makes most of the cell’s energy (ATP), is damaged. In this specific condition, activities of multiple respiratory chain complexes (usually I, III and IV) are reduced, so organs that need a lot of energy – like the inner ear, liver, kidneys, and hormone glands – are especially vulnerable and may fail early in life.

The disease usually starts in the newborn period. Babies may have deafness at birth, poor growth, low blood sugar, vomiting, and signs that the liver and other organs are not working well. The condition is inherited in an autosomal recessive pattern, which means a child must receive one faulty gene from each parent to be affected. It is extremely rare, with an estimated frequency of less than 1 in 1,000,000 people worldwide.

Other names

Different medical databases and research groups use several names for the same disease. These names all point to the same basic problem: a mitochondrial energy-making defect that presents mainly with deafness plus other body problems.

Common other names include:

1. Combined oxidative phosphorylation deficiency 34 (COXPD34) – the main formal name used in many genetic and rare disease databases.

2. Syndromic sensorineural deafness due to combined oxidative phosphorylation defect – highlights that hearing loss is part of a larger syndrome, not an isolated problem.

3. Syndromic sensorineural deafness due to COXPD – a shorter form used in some ontology and disease-mapping tools.

4. Syndromic sensorineural hearing loss due to COXPD – uses “hearing loss” instead of “deafness” but refers to the same underlying disease.

Types

Doctors do not officially divide this disease into fixed “types” with separate names, because it is already extremely rare and only a small number of families have been described. However, from the published case reports and summaries, we can think about clinical patterns or “types” based on which organs are most affected and how severe the disease is.

1. Hearing-dominant type – in some patients, the main problem is congenital or very early sensorineural hearing loss, with only mild or slowly developing problems in other organs. These children may mainly need hearing support and careful monitoring for later metabolic or endocrine issues.

2. Multisystem severe neonatal type – in others, the disease is very aggressive soon after birth. Babies may have profound deafness, severe lactic acidosis, repeated low blood sugar attacks, liver and kidney failure, and poor growth that may lead to death in childhood or teenage years.

3. Endocrine-involved type – some individuals with combined oxidative phosphorylation defects have inner-ear hearing loss along with hormone problems, such as high thyroid-stimulating hormone, primary ovarian failure or other endocrine gland failure. These patients can live longer but need long-term hormone replacement and monitoring.

4. Bone-marrow and liver-dominant type – in a few cases, features like pancytopenia (low red cells, white cells and platelets), liver enlargement, and liver failure are prominent, together with deafness. Here, energy failure in blood-forming cells and liver cells becomes the central issue.

These patterns show that the same underlying mitochondrial energy defect can look different from one person to another, even inside the same family.

Causes

The root cause of syndromic sensorineural deafness due to combined oxidative phosphorylation defect is genetic. However, many linked mechanisms and factors help explain why the disease happens and why it varies between people. Below are 20 causes and mechanisms, each explained in simple language.

1. Autosomal recessive mutations in the MRPS7 gene
   The main proven cause of COXPD34 is harmful changes (mutations) in a nuclear gene called MRPS7, which encodes a protein of the small subunit of the mitochondrial ribosome. When both copies of this gene are faulty, mitochondrial protein synthesis is disturbed, so several OXPHOS complexes cannot be built correctly, leading to combined respiratory chain deficiency.

2. Defective mitochondrial protein synthesis
   Because MRPS7 is part of the mitochondrial ribosome, mutations in this gene cause poor translation of mitochondrial DNA–encoded proteins. These proteins are essential components of respiratory chain complexes I, III, IV and V. When translation is impaired, these complexes are incomplete or unstable, and cells cannot produce enough ATP, harming tissues that need continuous energy such as the cochlea, liver and endocrine glands.

3. Combined respiratory chain complex deficiency (I, III, IV)
   In affected individuals, biochemical testing of tissues like liver or fibroblasts often shows low activity of multiple respiratory chain complexes (especially I, III and IV). This combined defect means that electrons cannot move smoothly along the chain, causing energy failure and accumulation of lactate and other metabolites, which damage cells over time.

4. Mitochondrial dysfunction in cochlear hair cells
   Inner-ear hair cells and spiral ganglion neurons have very high energy needs. Mitochondrial dysfunction from combined OXPHOS defects makes these cells unable to maintain ion gradients and to recover from daily sound-related stress, leading to permanent sensorineural hearing loss very early in life.

5. Energy failure in liver cells (hepatocytes)
   The liver carries out many energy-intensive tasks such as detoxification, protein synthesis and blood sugar control. When OXPHOS is severely impaired, liver cells cannot keep up with these jobs, leading to hepatomegaly (enlarged liver), poor clotting, jaundice and eventually liver failure in some patients.

6. Renal tubular and glomerular dysfunction
   Kidneys use a lot of ATP to filter blood and reabsorb vital salts and water. Combined OXPHOS defects weaken this process, causing renal dysfunction. Waste products may build up in the blood, salt balance may be disturbed and fluid retention or dehydration can occur, adding to the overall severity of the disease.

7. Lactic acidosis from impaired aerobic metabolism
   When mitochondria cannot perform oxidative phosphorylation properly, cells switch to anaerobic glycolysis. This produces excess lactic acid. Many patients with combined OXPHOS deficiency show raised serum lactate levels, which can cause acidosis, breathing difficulties, poor feeding and can worsen organ dysfunction.

8. Hypoglycemia due to disrupted energy and glucose control
   The liver normally stores and releases glucose to keep blood sugar steady. In severe mitochondrial disease, the liver cannot perform this balancing act well, and muscles also have impaired energy storage. This can cause intermittent or persistent low blood sugar (hypoglycemia), especially in newborns and infants, contributing to seizures, lethargy and feeding problems.

9. Endocrine gland failure (thyroid and adrenal)
   Endocrine glands like the thyroid and adrenal glands also depend on healthy mitochondria. Patients with this condition may develop high TSH levels (suggesting underactive thyroid) and primary adrenal insufficiency, where the adrenal glands cannot produce enough cortisol. Both problems arise from energy failure and damage within hormone-producing cells.

10. Gonadal dysfunction and hypergonadotropic hypogonadism
    In some individuals with combined OXPHOS defects, the ovaries or testes cannot function normally, leading to hypergonadotropic hypogonadism. This means high levels of pituitary hormones (FSH and LH) but low sex hormone production, causing delayed or absent puberty and infertility. Energy failure in gonadal tissue appears to be an important mechanism.

11. Bone-marrow failure leading to pancytopenia
    Blood-forming cells in the bone marrow are rapidly dividing and have high energy demands. Mitochondrial dysfunction can impair their function or survival, resulting in pancytopenia – low red blood cells, white blood cells and platelets. This can cause fatigue, infections and bleeding tendency, and it reflects systemic involvement of the energy defect.

12. Genetic background and modifier genes
    Even though MRPS7 is the main gene, other nuclear or mitochondrial genes may modify how severe the disease is. Differences in genes that control mitochondrial dynamics, antioxidant defenses or other OXPHOS components can alter the level of residual function, creating milder hearing-dominant forms or more severe multisystem disease in different individuals.

13. Heterozygous carrier status in parents
    Parents who each carry one faulty MRPS7 gene are usually healthy but can pass the mutation to their children. When a child inherits two faulty copies (one from each parent), the disease appears. In families with more than one affected child, this inheritance pattern clearly shows the autosomal recessive cause.

14. Mitochondrial oxidative stress in cochlear and liver cells
    When OXPHOS complexes are unstable, mitochondria can leak more reactive oxygen species (ROS). These toxic molecules damage proteins, lipids and DNA inside cells. The inner ear, liver and other highly active tissues are especially sensitive to this oxidative stress, which amplifies the damage caused by the primary genetic mutation.

15. Developmental vulnerability in the newborn period
    Many symptoms start at birth or soon after because this is a time when organs rapidly grow and change. Mitochondrial energy supply must suddenly increase after birth. If OXPHOS is defective, infants cannot meet this energy demand, so problems like failure to thrive, vomiting and liver failure appear early.

16. Possible contribution of infections or fever
    Fever and infection increase metabolic needs. In a child with combined OXPHOS deficiency, an infection can tip the balance from compensated to decompensated energy failure, worsening lactic acidosis, vomiting or organ failure. While infection does not cause the disease, it can trigger or unmask symptoms in a previously stable baby.

17. Nutritional stress and fasting
    Long periods without feeding or poor nutrition put extra stress on mitochondrial energy systems, especially in babies. In this disease, fasting can lower blood sugar and raise lactate more quickly than in healthy infants, leading to hypoglycemic episodes and metabolic crises, which may reveal the underlying defect.

18. Possible involvement of other OXPHOS-related genes
    Databases list several other genes involved in mitochondrial transporters and respiratory chain subunits as being associated, by text mining or experimental data, with the broader combined OXPHOS deficiency spectrum. These genes may not all be proven causes of this exact named syndrome, but they show that many different nuclear genes can disturb OXPHOS and lead to overlapping phenotypes with deafness.

19. Mitochondrial disease threshold effect
    Mitochondria exist in large numbers inside each cell. When enough mitochondria are dysfunctional, cell energy fails. This “threshold” effect helps explain why some tissues, like cochlea or liver, are more affected than others, and why disease can worsen over time as damage accumulates.

20. Random variation in mitochondrial and cellular resilience
    Even with the same gene mutation, individuals differ in how well their cells cope with stress. Differences in antioxidant capacity, mitochondrial turnover (mitophagy) and other protective systems may modify disease expression. This biological variation is another “cause” of why some patients have mainly deafness, while others develop life-threatening multi-organ failure.

Symptoms

The exact symptoms and how severe they are can differ widely between people, even in the same family. Below are 15 important symptoms reported in medical and rare-disease sources for this condition or the very closely related COXPD34 phenotype.

1. Congenital sensorineural hearing impairment
   The hallmark symptom is bilateral sensorineural deafness present at birth or in early infancy. The inner ear and auditory nerve cannot properly send sound signals to the brain. Parents may notice that the baby does not startle to loud noises or does not turn toward voices. Without early hearing support, speech and language development can be delayed.

2. Failure to thrive and poor weight gain
   Many infants with this disease grow more slowly than expected, a problem called “failure to thrive.” They may have poor feeding, frequent vomiting and low energy, so they do not gain weight or length along normal growth charts. This reflects the body’s difficulty in using and storing energy and in coping with repeated metabolic stress.

3. Recurrent vomiting
   Vomiting is common and may be related to metabolic acidosis, hypoglycemia or liver dysfunction. Parents may see frequent spit-ups that are more forceful than normal reflux, or episodes of severe vomiting during illness or fasting, which can quickly lead to dehydration and hospital visits.

4. Hypoglycemia (low blood sugar)
   Some children have episodes of low blood sugar, which can cause shakiness, sweating, irritability, sleepiness or even seizures if severe and untreated. This results from combined liver energy failure and increased whole-body energy needs, especially during fasting or infections.

5. Lactic acidosis
   Blood tests often show high lactate due to the switch from efficient mitochondrial energy production to less efficient anaerobic glycolysis. Clinically, lactic acidosis can cause rapid breathing, weakness, poor feeding and can worsen other organ problems.

6. Hepatomegaly (enlarged liver)
   Many affected children develop an enlarged liver, which a doctor can feel on abdominal examination. The liver may be swollen because liver cells are injured by chronic energy failure and fat accumulation, and because of scarring in severe cases.

7. Hepatic failure
   In serious cases, the liver cannot perform its normal jobs, leading to jaundice, bleeding problems, low blood proteins and accumulation of toxins. This liver failure can be life-threatening and is a major cause of hospital admission and poor outcome in some children with this condition.

8. Fever and recurrent illness
   Fever is listed as a common symptom and often accompanies infections. Because the immune system and energy supply are both stressed, affected children may have more severe reactions to otherwise routine infections, with worsening vomiting, lactic acidosis and hypoglycemia during fevers.

9. Pancytopenia (low blood cell counts)
   Some patients develop pancytopenia, with low red cells (anemia), low white cells and low platelets. This can cause fatigue, pale skin, frequent infections and easy bruising or bleeding. It reflects involvement of the bone marrow by the mitochondrial energy defect.

10. Primary adrenal insufficiency
    The adrenal glands may fail to produce enough cortisol and other hormones. Children can present with fatigue, weight loss, low blood pressure, episodes of severe illness during stress and sometimes darkening of the skin. Without treatment, adrenal crisis can be life-threatening.

11. Elevated thyroid-stimulating hormone (TSH)
    Blood tests may show high TSH with low or normal thyroid hormone levels, indicating hypothyroidism. Symptoms can include tiredness, poor growth, constipation and feeling cold, but in infants these signs may be subtle and found only on blood testing.

12. Hypergonadotropic hypogonadism
    As children grow, some may show delayed puberty. Laboratory tests reveal high gonadotropin levels (FSH and LH) but low sex hormones, indicating that the ovaries or testes are not working properly. This endocrine symptom may appear later than the hearing and liver problems.

13. Renal dysfunction
    Kidney problems may show as abnormal blood tests, protein or blood in the urine, or difficulty maintaining fluid and salt balance. Because kidney function is crucial for filtering toxins, impairment can worsen overall health and complicate management of lactic acidosis and other metabolic problems.

14. General fatigue and low exercise tolerance
    Even in milder or longer-surviving patients, tiredness and poor stamina are frequent. Children may become easily exhausted with play or walking. This reflects the global reduction in energy production in muscles and other tissues due to OXPHOS defects.

15. Developmental delay or learning difficulties in some cases
    While not reported in every case, some patients with combined OXPHOS deficiencies have global developmental delay or learning problems, which may result from energy failure in the brain, repeated metabolic crises, or limited sensory input from early deafness.

Diagnostic tests

Diagnosing syndromic sensorineural deafness due to combined oxidative phosphorylation defect usually needs a combination of clinical examination, hearing tests, metabolic tests, imaging and, finally, genetic testing. Below are 20 important tests, grouped into the categories you requested.

Physical examination tests

1. General pediatric physical examination
   A doctor examines the baby’s overall appearance, growth, skin color, breathing, heart sounds and abdomen. They look for signs like poor weight gain, jaundice, enlarged liver, dehydration or abnormal breathing. This broad examination helps raise suspicion that there is a systemic illness involving more than just the ears.

2. Growth measurement and growth-chart review
   Measuring weight, length/height and head circumference over time and plotting them on standard growth charts can show failure to thrive. Slow or falling growth curves are early clues to chronic metabolic or mitochondrial disease, especially when combined with feeding problems and vomiting.

3. Focused liver and abdominal examination
   The doctor gently feels the abdomen to check liver and spleen size, tenderness and fluid. An enlarged liver or signs of abdominal swelling support the possibility of hepatic involvement, which is common in combined OXPHOS deficiency syndromes.

4. Endocrine-focused examination
   Clinicians look for features of hormone problems, such as delayed puberty, small testicles or ovaries (on ultrasound), low blood pressure, skin changes or signs of hypothyroidism. These clinical clues guide further hormone testing and help define the full syndrome.

Manual (bedside/clinical) tests

5. Bedside hearing response checks in babies
   For newborns and very young infants, doctors and audiologists can perform simple behavioral tests, like observing startle or eye-widening responses to sudden loud sounds. Lack of response suggests significant hearing impairment and prompts more precise audiologic tests.

6. Tuning-fork tests (Rinne and Weber)
   In older children, simple metal tuning-fork tests can roughly separate sensorineural from conductive hearing loss. In this disease, Rinne is usually positive and Weber may lateralize, supporting an inner-ear rather than middle-ear problem, though full audiometry is still needed.

7. Neurological bedside examination
   A neurologic exam checks reflexes, tone, strength, coordination and basic cognitive function. While some children may have normal neurology, others may show hypotonia, poor coordination or developmental delay, suggesting wider mitochondrial brain involvement and guiding further imaging.

8. Clinical assessment for adrenal crisis or severe illness
   During episodes of vomiting, fever or collapse, clinicians assess blood pressure, heart rate, level of consciousness and hydration. This bedside assessment is crucial to detect adrenal crisis or severe metabolic decompensation, which require urgent treatment and later confirmatory lab tests.

Laboratory and pathological tests

9. Complete blood count (CBC)
   A CBC measures red cells, white cells and platelets. Pancytopenia (low values in all three lines) can be seen in some patients and supports the idea of bone-marrow involvement by the mitochondrial defect, as well as helping to explain infections and bleeding.

10. Serum lactate and pyruvate levels
    Elevated lactate, with or without abnormal pyruvate, is a key biochemical clue to mitochondrial OXPHOS dysfunction. These tests are usually taken when the child is unwell or fasting, and consistent elevation supports a diagnosis of a mitochondrial respiratory chain disorder.

11. Blood glucose and ketone testing
    Measuring blood sugar during illness or fasting detects hypoglycemia, which is common in this condition. Ketone levels may also be checked to understand how the body is using fat for energy. Repeated low glucose reinforces the suspicion of metabolic or mitochondrial disease affecting the liver.

12. Liver function tests (LFTs)
    Blood tests measuring liver enzymes, bilirubin, albumin and clotting factors assess how well the liver is working. Raised enzymes and low albumin or abnormal clotting suggest liver injury or failure, which fits the multisystem picture of combined OXPHOS deficiency.

13. Thyroid function tests (TSH, free T4)
    Because elevated circulating thyroid-stimulating hormone is described in this disease, checking TSH and thyroid hormone levels helps detect hypothyroidism. Treating this can improve growth and energy, even though it does not correct the mitochondrial defect itself.

14. Hormone tests for adrenal and gonadal function
    Blood cortisol, ACTH and, later in childhood, FSH, LH and sex hormones (estrogen or testosterone) are measured. Abnormal results reveal primary adrenal insufficiency and hypergonadotropic hypogonadism, helping to define the endocrine part of the syndrome and guide hormone replacement therapy.

15. Genetic testing for MRPS7 and related genes
    The most specific test is DNA analysis. Gene panels for mitochondrial disease or whole-exome/genome sequencing can detect pathogenic variants in MRPS7 and sometimes in other OXPHOS-related genes. Confirmation of biallelic MRPS7 mutations in a patient with the typical phenotype establishes the diagnosis of syndromic sensorineural deafness due to combined OXPHOS defect.

Electrodiagnostic tests

16. Auditory brainstem response (ABR) testing
    ABR uses small electrodes on the scalp to measure the brain’s electrical response to sound clicks. It can test hearing in newborns and infants without needing active cooperation. In this disease, ABR typically shows absent or severely reduced responses, confirming profound sensorineural hearing loss.

17. Otoacoustic emissions (OAE)
    OAE tests measure tiny sounds produced by the outer hair cells in the cochlea. In sensorineural deafness due to hair-cell damage, OAEs are usually absent. Combined with ABR, these tests show that the hearing loss is cochlear and not due to middle-ear problems, supporting a mitochondrial inner-ear cause.

18. Standard audiometry in older children
    For children old enough to cooperate, pure-tone and speech audiometry quantify the degree of hearing loss at different frequencies. These tests monitor progression over time and help decide on management such as hearing aids or cochlear implants, which are often needed in mitochondrial hearing loss.

Imaging tests

19. Abdominal ultrasound (especially liver and kidneys)
    Ultrasound is a painless imaging test that uses sound waves to look at organs. In this disease, it can show an enlarged or structurally abnormal liver and kidneys, supporting the clinical and laboratory evidence of multisystem mitochondrial involvement.

20. Brain and inner-ear MRI
    MRI of the brain can look for structural abnormalities, leukodystrophy or other signs of mitochondrial encephalopathy that sometimes accompany combined OXPHOS defects. High-resolution MRI of the inner ear may also exclude structural malformations and confirm that the hearing problem is functional (metabolic) rather than due to missing cochlear structures.

Non-pharmacological treatments (therapies and others )

1. Genetic counselling and family planning
Genetic counselling helps the family understand what gene change causes the disease, how it is inherited, and the chance that future children may be affected. A counsellor explains test results in simple terms and supports emotional coping. Families can discuss options such as carrier testing, prenatal testing, or pre-implantation genetic testing. This does not treat the child directly, but it can prevent new cases and reduce anxiety by giving clear, honest information.

2. Newborn and early hearing screening
Babies at risk for mitochondrial disease or with a family history of deafness should have early and repeated hearing checks. Simple tests using small probes in the ear can detect hearing loss before speech delay appears. Early diagnosis allows quick fitting of hearing aids or referral for cochlear implant assessment. Detecting hearing loss early is one of the strongest ways to protect language, school performance, and social development in this condition.

3. Hearing aids
For children whose hearing loss is mild to moderate, digital hearing aids can amplify sounds and speech. Behind-the-ear devices send sounds through a mould into the ear canal. Audiologists adjust the settings to match the child’s hearing profile and can re-program them as hearing changes. With training and family support, hearing aids can greatly improve awareness of speech and environmental sounds, even though they cannot stop the progression of the mitochondrial disease itself.

4. Cochlear implantation
When hearing loss is severe or profound and hearing aids no longer help, a cochlear implant can be considered. This device bypasses damaged hair cells and directly stimulates the hearing nerve with electrical signals. Studies show many people with mitochondrial deafness gain better speech perception and long-term hearing performance after implantation, especially if surgery is done early and there is careful follow-up. However, results can vary, and the decision requires a specialist implant team.

5. Speech and language therapy
Speech-language therapists work with the child to develop understanding and use of language, either through spoken words, sign language, or both. Therapy may focus on listening skills with hearing aids or implants, articulation, vocabulary, and social communication. Parents are taught simple exercises to practise at home. Early, regular therapy helps the child build strong communication even if hearing continues to decline over time.

6. Sign language and visual communication
Some families choose to learn sign language (such as national or regional sign languages) as a main or back-up communication system. Visual communication methods like signs, gestures, pictures, and text give the child a reliable way to express needs and feelings even during times when hearing devices are not working. Starting sign language early can reduce frustration, support self-esteem, and allow the child to join Deaf culture and community if they wish.

7. Auditory-verbal therapy (AVT)
For families who want to focus on spoken communication with hearing aids or cochlear implants, auditory-verbal therapy trains the brain to make sense of sounds. The therapist teaches the child to listen actively and to use hearing as the main channel for language learning. Parents learn how to talk close to the child’s microphone, reduce background noise, and build listening into daily routines. AVT can improve speech clarity and understanding in many children with implants.

8. Individualised educational support (IEP)
Children with combined OXPHOS defect and deafness often need tailored school plans. This may include classroom FM systems, captioning, written instructions, extra time for tests, and seating near the teacher. Some children also have learning difficulties or fatigue from mitochondrial disease, so schedules may need to be flexible. A personalised education plan helps teachers understand the condition and gives the child the best chance to succeed in school.

9. Physical therapy (physiotherapy)
Because mitochondrial disease can cause low muscle tone, weakness, and poor balance, physiotherapists teach safe exercises to build strength and endurance. Gentle, regular activity can improve walking, coordination, and stamina without over-tiring the child. The therapist also advises on splints, walkers, or wheelchairs if needed. Properly paced exercise may even support mitochondrial function and quality of life when monitored carefully.

10. Occupational therapy
Occupational therapists help the child manage daily tasks such as dressing, writing, using cutlery, and playing. They can suggest special tools (adaptive equipment) and ways to save energy, like sitting while doing tasks or breaking chores into small steps. This is important because children with mitochondrial disease often fatigue easily. Good occupational support protects independence and reduces stress for the whole family.

11. Vision monitoring and support
Some combined OXPHOS defects also affect the eyes, causing optic nerve problems or retinal changes. Regular eye checks can detect early vision loss. Low-vision aids, large-print materials, and classroom modifications can then be used to compensate. When both hearing and vision are affected, early support is vital to keep communication channels open and to prevent isolation.

12. Energy conservation and pacing
Because the child’s cells cannot make energy efficiently, over-activity can worsen fatigue and other symptoms. Families can learn pacing strategies, such as balancing activity with rest, planning demanding tasks for earlier in the day, and avoiding long periods of fasting or extreme heat. Pacing does not cure the disease but can reduce “crashes” and hospital visits by respecting the body’s limited energy reserves.

13. Structured aerobic exercise (under supervision)
Moderate, carefully increased aerobic exercise (such as walking, cycling, or swimming) can help improve fitness and mitochondrial function in some people with mitochondrial disease. Exercise programmes must be designed by specialists and increased slowly to avoid over-exertion. When done correctly, training may increase muscle efficiency, reduce fatigue, and improve mood and sleep. It should always be coordinated with the treating metabolic or neuromuscular team.

14. Avoidance of mitochondrial toxins and ototoxic drugs
Certain medicines, such as aminoglycoside antibiotics and some chemotherapy agents, can damage hearing. Other drugs, like valproic acid, may worsen mitochondrial function. Families should carry a drug “alert” card listing unsafe or high-risk medicines. Doctors can then choose safer alternatives whenever possible. Avoiding these triggers will not correct existing deafness but may slow further hearing and organ damage.

15. Psychological counselling and family support
Chronic illness, hearing loss, and uncertain prognosis can cause anxiety, sadness, or behaviour problems. Psychologists or counsellors can help the child and family process feelings, learn coping skills, and communicate better. Support groups with other families facing mitochondrial disease or deafness can also create a sense of community and hope. Emotional support is as important as medical care in long-term rare disorders.

16. Nutritional assessment and dietetic support
Dietitians familiar with mitochondrial disease can assess growth, nutrient intake, and feeding difficulties. They may recommend small frequent meals, adequate carbohydrates, and enough protein to support growth and muscle repair. They also advise on safe use of supplements and on avoiding extreme diets or long fasting. Good nutrition is a foundation for all other treatments in children with energy production disorders.

17. Environmental noise control and classroom acoustics
Reducing background noise makes it easier for a child with hearing aids or implants to understand speech. Simple steps include adding soft furnishings, closing doors and windows, using carpets, and turning off unnecessary fans or devices. In classrooms, sound-field systems or FM transmitters can bring the teacher’s voice directly to the child’s device. Better acoustics reduce listening fatigue and improve learning.

18. Assistive listening devices and technology
Remote microphones, FM systems, Bluetooth streamers, captioned phones, and real-time captioning apps can all help the child access speech more clearly. Many cochlear implants and hearing aids can link directly to tablets and phones for audio streaming. Using modern technology in a thoughtful way allows the child to join conversations at home, in class, and online more easily.

19. Balance and fall-prevention training
If the inner ear or brain pathways are affected, balance may be poor. Physiotherapists or vestibular therapists can teach exercises to train balance, eye–head coordination, and safe movement. Simple home modifications like removing loose rugs, adding grab bars, and using night-lights can lower the risk of falls. This is especially important for children with muscle weakness or seizures.

20. Multidisciplinary mitochondrial clinic care
Because this condition affects many organs, coordinated care in a specialised mitochondrial or metabolic clinic is ideal. A team may include neurologists, geneticists, audiologists, ENT surgeons, cardiologists, nephrologists, dietitians, physiotherapists, and psychologists. Regular team reviews allow early detection of new problems and ensure that treatments do not conflict with each other. Team-based care improves safety and long-term outcomes in complex mitochondrial disorders.

---

Drug treatments

Important note: There is no medicine that cures this mitochondrial defect. Most drugs are used off-label to support energy metabolism, treat complications, or control symptoms. Exact dose and schedule must always be decided by a specialist doctor. Do not change or start any medicine without your own doctor’s advice.

1. Levocarnitine (Carnitor®)
Levocarnitine is a natural substance that helps long-chain fats enter mitochondria to be used as energy. FDA-approved products are used for primary and some secondary carnitine deficiency, and many mitochondrial experts give it when blood carnitine levels are low. Labels describe adult oral doses around 1–3 g per day in divided doses, adjusted by clinical response. Main side effects are fishy body odour, nausea, and diarrhoea. It may improve fatigue and exercise tolerance in selected patients but evidence is mixed.

2. Riboflavin (Vitamin B2, high-dose)
Riboflavin is a water-soluble vitamin needed to make FAD and FMN, which are cofactors for mitochondrial enzymes, including complex I and II. High-dose riboflavin is often used in mitochondrial disease and some specific riboflavin-responsive disorders. Typical doses in studies are much higher than in food and must be prescribed by a doctor. It is generally well tolerated; bright yellow urine is common and harmless. In some patients, riboflavin has been linked with improved muscle strength and reduced frequency of other symptoms.

3. Thiamine (Vitamin B1)
Thiamine is a cofactor for pyruvate dehydrogenase and other key enzymes that feed into the Krebs cycle and respiratory chain. In some mitochondrial and related disorders, high-dose thiamine may improve lactic acidosis, fatigue, and neurological symptoms. It is usually given orally in doses above normal dietary needs, guided by the specialist. Thiamine is generally safe, with rare allergic reactions when given by injection. It supports energy metabolism but does not fix the underlying gene change.

4. Coenzyme Q10 (ubiquinone or ubiquinol)
Coenzyme Q10 sits inside the mitochondrial membrane and transfers electrons between complexes I/II and III. Supplemental CoQ10 (often as ubiquinol) is widely used in many primary mitochondrial diseases. Although not FDA-approved specifically for mitochondrial disease, clinical trials and case series show improved exercise tolerance, reduced lactate, or better quality of life in some patients. Doses vary by weight; common side effects are mild stomach upset or insomnia. It is usually part of a broader “mito-cocktail” rather than a stand-alone cure.

5. Alpha-lipoic acid
Alpha-lipoic acid is an antioxidant and cofactor in mitochondrial dehydrogenase complexes. It can help scavenge free radicals produced by faulty respiratory chain function. In mitochondrial and neurodegenerative conditions, alpha-lipoic acid is often used as part of antioxidant therapy. It is taken orally, usually with meals. Side effects are usually mild (nausea, rash), but high doses may lower blood sugar, so careful monitoring is needed in people with diabetes.

6. L-arginine
L-arginine is a semi-essential amino acid that helps produce nitric oxide and supports blood vessel function. It is best studied in MELAS, another mitochondrial disorder, where intravenous or high-dose oral arginine can treat or reduce stroke-like episodes. In combined OXPHOS defects, arginine may be used to support blood flow and energy metabolism during metabolic stress, but evidence is limited. Side effects include nausea, diarrhoea, and low blood pressure at high doses.

7. Vitamin C and Vitamin E
Vitamin C (water-soluble) and vitamin E (fat-soluble) are common antioxidant vitamins in mitochondrial “cocktails.” They help neutralise free radicals produced by damaged respiratory chain complexes and protect cell membranes. They are usually given orally at doses above simple dietary recommendations but within safe limits set by professional guidelines. Side effects are uncommon but very high doses may upset the stomach (vitamin C) or increase bleeding risk (vitamin E) in susceptible people.

8. Biotin and folinic acid (leucovorin)
Biotin and folinic acid support carboxylase enzymes and folate-dependent pathways important for brain and mitochondrial function. They are essential in some specific metabolic and mitochondrial disorders. In combined OXPHOS defects, they are sometimes added when there is uncertainty about overlapping conditions. They are generally safe, but like all vitamins, they should not be given in very high doses without medical supervision.

9. Antiepileptic drugs (for seizures)
If the child has seizures, antiepileptic drugs such as levetiracetam or lamotrigine may be used. Doctors try to avoid valproic acid in many mitochondrial diseases because it can worsen liver function and mitochondrial toxicity. Seizure drugs do not treat the energy defect but they protect the brain from repeated seizures, which can cause further damage. Doses and schedules are highly individual and must be guided by a neurologist.

10. Acid-buffering agents (bicarbonate or citrate)
Some patients develop chronic lactic acidosis because their mitochondria cannot use pyruvate efficiently. Doctors may use sodium bicarbonate or citrate to buffer acidity and protect organs. These medicines can be given orally or intravenously, usually in hospital or under close monitoring. The main risks include changes in blood sodium, potassium, and pH, so blood tests are needed. They help control a complication of the disease, not the root cause.

---

Dietary molecular supplements

These supplements are often combined in a “mitochondrial cocktail.” Evidence is limited but some patients and clinicians report benefits in energy and function. Always use them under medical supervision.

1. Coenzyme Q10 – supports electron transport and acts as an antioxidant.

2. Riboflavin (B2) – cofactor for complex I and II.

3. Thiamine (B1) – supports pyruvate dehydrogenase and Krebs cycle entry.

4. Alpha-lipoic acid – antioxidant and enzyme cofactor.

5. L-carnitine – carries long-chain fats into mitochondria when deficient.

6. NADH / B-complex vitamins – support many enzymes in energy pathways.

7. Vitamin D – supports bone, immune, and muscle function.

8. Omega-3 fatty acids – support cell membranes and anti-inflammatory pathways.

9. Vitamin C and E – protect against oxidative stress in water and fat phases.

10. Magnesium – cofactor in ATP reactions and may help with cramps and migraines.

Each is usually given orally, in weight- and age-adjusted doses determined by the metabolic team. Side effects are generally mild but interactions with other medicines must still be checked.

---

Immunity-booster and regenerative / stem-cell–related approaches

At present, there are no approved stem-cell or gene-editing drugs specifically for combined oxidative phosphorylation defects with deafness. Research areas include:

• Optimised mitochondrial cocktails and antioxidants to reduce ongoing oxidative damage and support cell survival.

• Experimental gene therapies aimed at correcting specific nuclear or mitochondrial DNA mutations in research settings.

• Mitochondrial replacement or transfer techniques being explored for prevention of transmission in certain mtDNA disorders.

• Stem-cell-based strategies to repair inner-ear hair cells or neurons, which are still at an early experimental stage.

These approaches are mainly in trials or animal studies. Families should ask about clinical trial options in specialised centres but avoid unregulated “stem cell” clinics that make unrealistic promises.

---

Surgeries

1. Cochlear implantation
As described earlier, cochlear implantation is the main surgery directly targeting hearing in this condition. An electrode array is placed inside the cochlea and connected to an external speech processor. Studies in mitochondrial deafness show long-term improvement in speech perception for many patients, although results vary and some may have gradual decline if auditory pathways in the brainstem are also affected. Careful pre-operative evaluation and long-term follow-up are essential.

2. Gastrostomy tube placement
If swallowing is unsafe or feeding takes very long because of fatigue, a feeding tube can be placed directly into the stomach through the abdominal wall. This surgery allows safe delivery of calories, fluids, and medicines, and prevents aspiration. It can reduce stress at meal times and support better growth. The decision is usually made by a multidisciplinary team with the family after trying less invasive options.

3. Orthopaedic surgery for contractures or scoliosis
Some children develop tight joints, hip dislocation, or spinal curvature due to muscle weakness and abnormal tone. Orthopaedic surgery can correct severe deformities, improve comfort, and make sitting, standing, or walking easier. It is usually combined with long-term physiotherapy. Because anaesthesia can be risky in mitochondrial disease, surgery is carefully planned with anaesthetists who know mitochondrial safety guidelines.

4. Liver or kidney transplantation (selected cases)
In very severe cases with end-stage liver or kidney failure, transplantation may be considered. This is complex in mitochondrial disorders, because the underlying systemic disease remains, and outcomes vary. In selected patients with mainly liver involvement, transplant may improve survival. The risks and benefits must be weighed very carefully by experienced transplant and mitochondrial teams.

5. Ventilation or airway surgeries
If the child has severe sleep apnoea or difficulty protecting the airway due to neurological involvement, procedures such as tonsillectomy, adenoidectomy, or even tracheostomy in extreme cases may be used. These surgeries do not treat the mitochondrial defect but can reduce night-time hypoxia and improve sleep quality and daytime functioning.

---

Preventions

Because this is a genetic disease, we cannot prevent the root cause in the affected child, but we can reduce complications and prevent new cases in the family:

1. Genetic counselling for parents and extended family before future pregnancies.

2. Prenatal or pre-implantation genetic testing where legal and available.

3. Avoidance of known mitochondrial-toxic and ototoxic drugs whenever possible.

4. Up-to-date vaccinations, including flu and pneumonia vaccines, to reduce serious infections.

5. Prompt treatment of fevers and infections to avoid metabolic decompensation.

6. Careful planning of anaesthesia and surgery with teams experienced in mitochondrial disease.

7. Avoiding prolonged fasting or dehydration, especially during illness.

8. Protecting ears from loud noise, which could add extra damage to already fragile hearing.

9. Healthy lifestyle habits (sleep, diet, gentle exercise) to support general resilience.

10. Regular specialist follow-up to catch new organ involvement early.

---

When to see doctors

Families should stay in regular contact with a mitochondrial or metabolic specialist, an audiologist, and a paediatrician. You should seek urgent medical attention if the child has sudden worsening of hearing, new seizures, severe headache, repeated vomiting, breathing problems, chest pain, extreme sleepiness, or any rapid change in movement, vision, or behaviour. These may signal a metabolic crisis, stroke-like event, serious infection, or organ failure. Even for milder changes, such as slow decline in school performance, increasing fatigue, or feeding difficulties, early review allows the team to adjust treatment before complications become severe.

---

What to eat and what to avoid

Most experts recommend a balanced diet with enough calories, complex carbohydrates, and protein for growth. Small, frequent meals can help avoid long fasts and keep blood sugar stable. Plenty of fluids are important, especially during illness. Dietitians may suggest foods rich in natural antioxidants (fruits, vegetables), healthy fats (olive oil, nuts, oily fish), and lean protein (beans, eggs, poultry, fish) to support muscles and energy metabolism.

Families are usually advised to avoid extreme or fad diets, such as very low-carbohydrate or high-protein regimes, unless specifically prescribed by the metabolic team. Very high sugar intake, large amounts of caffeine, alcohol (for adults), and smoking are discouraged because they can stress the body and worsen oxidative damage. Unregulated mega-dose supplements and online “miracle cures” should also be avoided, as they may interact with medicines or harm the liver and kidneys. All dietary changes should be checked with the child’s own doctors and dietitian.

---

FAQs

1. Is this condition curable?
At present there is no cure that can correct the underlying gene change or fully normalise mitochondrial energy production. Treatment focuses on supporting hearing with devices and therapy, protecting organs, and improving quality of life through medicines, supplements, and lifestyle changes. Research into gene therapy and mitochondrial-targeted drugs is active but still experimental.

2. Will my child’s hearing always get worse?
The course can be different for each person. Some children have stable, severe deafness from birth; others have progressive loss that worsens over time. Early fitting of hearing aids or cochlear implants and strong communication support (oral, sign, or both) help the child communicate well, even if hearing declines. Regular hearing tests are important to track changes and adjust devices.

3. Can cochlear implants work in mitochondrial deafness?
Many case reports and reviews show that cochlear implants can give good and sometimes long-lasting improvements in speech understanding for people with mitochondrial hearing loss, especially when implanted early. However, outcomes vary, and some patients may have limited benefit if the hearing nerve or brain pathways are severely affected. A specialised implant team can discuss expected benefits and risks for each child.

4. Are the “mito-cocktail” supplements proven?
Supplements like CoQ10, carnitine, riboflavin, alpha-lipoic acid, and vitamins C and E are widely used and have a good safety record when monitored. Many patients and clinicians report improved energy and fewer “bad days.” However, controlled clinical trials are still limited, and not everyone responds. They should be seen as supportive tools, not cures, and always used under medical guidance.

5. Can my child exercise safely?
Yes, in most cases, but exercise must be carefully planned. Gentle, regular aerobic exercise designed by a physiotherapist and metabolic doctor can improve fitness and mitochondrial function. Over-exertion, dehydration, or exercising when very ill can be dangerous. The key is pacing, gradual progression, and stopping if symptoms like chest pain, severe breathlessness, or extreme fatigue appear.

6. Will other organs definitely be affected?
Not always. Combined OXPHOS defects can involve many organs, but the pattern and severity vary. Some people mainly have hearing loss and mild muscle symptoms, while others develop serious liver, kidney, heart, or brain problems. Regular monitoring with blood tests, heart tests, and imaging helps detect issues early so they can be managed promptly.

7. Is pregnancy safe for someone with this condition?
Pregnancy in women with mitochondrial disease needs careful planning. Energy demands rise during pregnancy, and there may be added strain on the heart and other organs. Genetic counselling can explain the risk of passing on the condition. A high-risk obstetric team and mitochondrial specialist should manage pregnancy and birth together.

8. What can families do right now to help?
Focus on building strong communication (hearing devices, sign, visual aids), keeping vaccinations up to date, following dietary and supplement plans, and attending regular specialist reviews. Learn about pacing and energy conservation, and seek emotional and practical support from counsellors and patient organisations. Small, consistent steps in daily life make a big difference over time, even when there is no cure yet.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: February 25, 2025.